News
AudioCodes (AUDC) Q2 Earnings Lag Estimates
AudioCodes (AUDC) came out with quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.18 per share a year ago. These figures
Lithia Motors (LAD) Beats Q2 Earnings and Revenue Estimates
Lithia Motors (LAD) came out with quarterly earnings of $10.24 per share, beating the Zacks Consensus Estimate of $9.78 per share. This compares to earnings of $7.87 per share a year ago. These
Can Qualcomm Shock Wall Street With Its Q3 Earnings?
Semiconductor giant Qualcomm Inc. (NASDAQ: QCOM) is set to report earnings on Wednesday, and it couldn’t come at a more pivotal moment. The stock has been in a quiet but steady uptrend since
Is Franklin Natural Resources A (FRNRX) a Strong Mutual Fund Pick Right Now?
If you have been looking for Sector - Energy funds, a place to start could be Franklin Natural Resources A (FRNRX). FRNRX has a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various
Is Baron Emerging Markets Retail (BEXFX) a Strong Mutual Fund Pick Right Now?
Have you been searching for a Non US - Equity fund? You might want to begin with Baron Emerging Markets Retail (BEXFX). BEXFX holds a Zacks Mutual Fund Rank of 3 (Hold), which is based on various
Is Glenmede Disciplined US Eq (GTLOX) a Strong Mutual Fund Pick Right Now?
There are plenty of choices in the Large Cap Growth category, but where should you start your research? Well, one fund that may not be worth investigating is Glenmede Disciplined US Eq (GTLOX)
Is Schwab MarketTrack Growth Investor (SWHGX) a Strong Mutual Fund Pick Right Now?
If you have been looking for Allocation Balanced funds, a place to start could be Schwab MarketTrack Growth Investor (SWHGX). SWHGX carries a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based
Is T. Rowe Price Personal Strategy Growth (TRSGX) a Strong Mutual Fund Pick Right Now?
If investors are looking at the Index fund category, T. Rowe Price Personal Strategy Growth (TRSGX) could be a potential option. TRSGX carries a Zacks Mutual Fund Rank of 2 (Buy), which is based on
Nike Stock: JPMorgan Upgrade Fuels 4% Price Surge
After a prolonged downward trend since late 2021, Nike's stock showed significant signs of recovery on Monday, jumping approximately 4% and leading the Dow Jones. This impressive rally was triggered
Gold ETFs to Remain Strong Despite the Stock Market Rally
Rising global trade tensions and fears over ballooning fiscal debt are driving investors toward safe-haven assets, strengthening gold’s position as a key refuge. This has led analysts in a Reuters
New Strong Buy Stocks for July 29th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Mission Produce, Inc. AVO: This fruits producer has seen the Zacks Consensus Estimate for its current year earnings
New Strong Sell Stocks for July 29th
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Burford Capital Limited BUR is a legal finance products and services company. The Zacks Consensus Estimate for its current
Exelixis Stock: Mixed Signals After Earnings Beat
Biotech company Exelixis delivered notably mixed second-quarter 2025 results, creating divergent investor reactions. The California-based firm reported earnings per share of $0.75, significantly
Best Growth Stocks to Buy for July 29th
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, July 29th:
Afya Limited AFYA:This medical education group from Brazil carries a Zacks Rank #1
Technology ETF (XLK) Hit a 52-Week High
For investors seeking momentum, Technology Select Sector SPDR ETF XLK is probably on the radar. The fund just hit a 52-week high and is up 52.5% from its 52-week low of $172.45 per share.
But are
Best Value Stocks to Buy for July 29th
Here are three stocks with buy rank and strong value characteristics for investors to consider today, July 29th:
The Progressive Corporation PGR: This property-casualty insurance products and
Should SPDR Portfolio S&P 500 High Dividend ETF (SPYD) Be on Your Investing Radar?
Looking for broad exposure to the Large Cap Value segment of the US equity market? You should consider the SPDR Portfolio S&P 500 High Dividend ETF (SPYD), a passively managed exchange traded fund
Should Vanguard Mid-Cap Value ETF (VOE) Be on Your Investing Radar?
Looking for broad exposure to the Mid Cap Value segment of the US equity market? You should consider the Vanguard Mid-Cap Value ETF (VOE), a passively managed exchange traded fund launched on
Should Goldman Sachs MarketBeta U.S. 1000 Equity ETF (GUSA) Be on Your Investing Radar?
Looking for broad exposure to the Large Cap Blend segment of the US equity market? You should consider the Goldman Sachs MarketBeta U.S. 1000 Equity ETF (GUSA), a passively managed exchange traded
Should Franklin U.S. Large Cap Multifactor Index ETF (FLQL) Be on Your Investing Radar?
Designed to provide broad exposure to the Large Cap Blend segment of the US equity market, the Franklin U.S. Large Cap Multifactor Index ETF (FLQL) is a passively managed exchange traded fund
Should First Trust Dow 30 Equal Weight ETF (EDOW) Be on Your Investing Radar?
Designed to provide broad exposure to the Large Cap Blend segment of the US equity market, the First Trust Dow 30 Equal Weight ETF (EDOW) is a passively managed exchange traded fund launched on
Should You Invest in the First Trust Indxx NextG ETF (NXTG)?
Launched on February 17, 2011, the First Trust Indxx NextG ETF (NXTG) is a passively managed exchange traded fund designed to provide a broad exposure to the Technology - Telecom segment of the
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
The Inspire Corporate Bond ETF (IBD) was launched on 07/10/2017, and is a smart beta exchange traded fund designed to offer broad
Should You Invest in the iShares U.S. Infrastructure ETF (IFRA)?
Looking for broad exposure to the Utilities - Infrastructure segment of the equity market? You should consider the iShares U.S. Infrastructure ETF (IFRA), a passively managed exchange traded fund
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the Invesco Biotechnology & Genome ETF (PBE), a passively managed exchange



